Home

Home

article image

Acceleware launches the AxRecon™ Image Reconstruction Solution

Image reconstruction for Computed Tomography (CT) Scanners often takes hours of processing time and represents a major barrier to efficiency for many organizations. Acceleware Corp. offers a solution with the launch of its AxRecon image reconstruction solution for the medical imaging, security, and non-destructive testing markets. It reduces the time required to complete this work from hours to minutes to speed up the imaging workflow.

“Our entry into the medical and commercial imaging market space represents a significant growth opportunity for Acceleware, and is consistent with Acceleware’s long-term growth strategy to tackle new markets,” said Sean Krakiwsky, CEO of Acceleware. “The benefits of higher throughput and image quality that are already being realized by early customers of AxRecon™ will help us drive adoption of this product within the broader imaging market.”
The long processing time required for CT image reconstruction limits throughput and quality for companies, clinicians, and researchers. In order to meet the demands of their workload, these users often sacrifice image quality to save on processing time. AxRecon works with existing cone beam CT scanners to eliminate the bottleneck by significantly speeding up filtered back projection computations. This enables medical and commercial users to accelerate the reconstruction of their data and improve the quality of their images without disrupting their current workflow.
The AxRecon solution combines Acceleware’s proprietary software acceleration libraries with the massive parallel processing power of NVIDIA® Graphic Processing Units (GPUs) to dramatically increase the speed of sophisticated computations. AxRecon seamlessly integrates with existing CT scanners with minimal setup. By accelerating algorithms such as filtered back-projection image reconstruction, clients are able to increase the speed of their operations and quality of their end results, while reducing the energy use and physical footprint of their high performance computing systems.
“In biomedical micro-computed tomography applications, the volume dimensions of our reconstructions have increased dramatically over the past few years,” said David Holdsworth of Robarts Imaging.  “During the same period, scan times have also been reduced; this makes cone-beam CT reconstruction time the bottleneck that limits workflow in some situations.  GPU-based reconstruction is a cost-effective solution for this task, and we have found that Acceleware’s AxRecon product can provide 3D reconstructions up to 50 times faster than a single-CPU.”
Please visit Acceleware at ECR in Booth: #435, taking place this week in Vienna, Austria. For more information on the AxRecon solution including customer case studies and whitepapers, please go to

This article was published on 03/08/2008

Search

 

Service

Company News

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.